Neurovascular changes measured by time-of-flight MR angiography in cholesterol-fed rabbits with cortical amyloid β-peptide accumulation

Journal of Magnetic Resonance Imaging

Volumn 32, Issue 2, 2010, Pages 306-314

  Lemieux, Susan K ^a   Smith Bell, Carrie A ^b   Wells, Jered R ^b,d   Ezerioha, Nnadozie M ^b   Carpenter, Jeffrey S ^b   Sparks, D Larry ^c   Schreurs, Bernard G ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SUN HEALTH RESEARCH INSTITUTE   (United States)

^d Central College   (United States)

Author keywords

A ; Alzheimer's disease; Amyloid peptide; Angiography; Cerebrovascular; Cholesterol; Copper; MRI; Rabbit; Stroke; TOF MRA

Indexed keywords

AMYLOID BETA PROTEIN; CHOLESTEROL;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DIAMETER; ARTICLE; BASILAR ARTERY; BRAIN ANGIOGRAPHY; BRAIN ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; HIPPOCAMPUS; HYPERCHOLESTEROLEMIA; LIPID DIET; MAGNETIC RESONANCE ANGIOGRAPHY; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; POSTERIOR CEREBRAL ARTERY; PRIORITY JOURNAL; RABBIT; RADIOFREQUENCY; RISK FACTOR; STROKE; TEMPORAL CORTEX;

AMYLOID BETA-PEPTIDES; ANIMAL FEED; ANIMALS; BLOOD VESSELS; CEREBRAL CORTEX; CHOLESTEROL; DIET; DIETARY FATS; DISEASE MODELS, ANIMAL; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; RABBITS; RISK; STROKE;

EID: 77955394218     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22244     Document Type: Article

References (63)

1. Desmond DW Tatemichi TK, Paik M, Stern Y. Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort. Arch Neurol 1993;50:162-166. (Pubitemid 23054799)
2. Jarvik GP, Wijsman EM, Kukull WA, Schellenberg GD, Yu C, Larson EB. Interactions of apolipoprotein E genotype, total cholesterol level, age, sex in prediction of Alzheimer's disease: A casecontrol study. Neurology 1995;45:1092-1096.
3. Mainous AG III, Eschenbach SL, Wells BJ, Everett CJ, Gill JM. Cholesterol, transferrin saturation and the development of dementia and Azlheimer's disease: Results from an 18-year population-based cohort. Fam Med 2005;37:36-42.
4. Sparks DL. Dietary cholesterol induces Alzheimer-like beta-amyloid immunoreactivity in rabbit brain. Nutr Metab Cardiovasc Dis 1997;7:255-266.
5. Brenner SR. Neurovascular unit dysfunction: A vascular component of Alzheimer disease? Neurology 2008;70:243-244.
6. Esiri MM. Which vascular lesions are of importance in vascular dementia? Ann N Y Acad Sci 2000;903:239-243.
7. Hooijmans CR, Rutters F, Dederen PJ, et al. Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD). Neurobiol Dis 2007;28:16-29.
8. Zlokovic BV. New therapeutic targets in the neurovascular pathway in Alzheimer's disease. Neurotherapeutics 2008;5:409-414. (Pubitemid 351952489)
9. Mandybur TI. The incidence of cerebral amyloid angiopathy in Alzheimer's disease. Neurology 1975;25:120-126.
10. Chandra V PR. Gene-environment interaction in Alzheimer's disease: A potential role for cholesterol. Neuroepidemiology 1998;17:225-232.
11. Dufouil C, Richard F, Fievet N, et al. ApoE genotype, cholesterol level, lipid-lowering treatment and dementia. The three-city study. Neurology 2005;64:1531-1538.
12. Sparks D. Coronary artery disease, hypertension, ApoE, and cholesterol: A link to Alzheimer's disease? Ann N Y Acad Sci 1997;826:128-146.
13. Sparks DL, Martin TA, Gross DR, Hunsaker JC III. Link between heart disease, cholesterol, and Alzheimer's disease: A review. Microsc Res Tech 2000;50:287-290. (Pubitemid 30651168)
14. Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM. Dietary fat intake and the risk of incident dementia in the Rotterdam study. Ann Neurol 1997;42:776-782. (Pubitemid 27481550)
15. Kuo YM, Emmerling MR, Bisgaier CL, et al. Elevated low-density lipoprotein in Alzheimer's disease correlates with brain A-beta 1-42 levels. Biochem Biophys Res Communication 1998;252:711-715.
16. Weiner MF, Cullum CM, Rosenberg RN, Honig LS. Aging and Alzheimer's disease: Lessons from the Nun Study. Gerontologist 1998;38:5-6.
17. Popescu BO. Still debating a cause and diagnostic criteria for Alzheimer's disease. J Cell Mol Med 2007;11:1225-1226.
18. Purandare N, Burns A, Daly KJ, et al. Cerebral emboli as a potential cause of Alzheimer's disease and vascular dementia: Case-control study. BMJ 2006;332:1119-1124. (Pubitemid 44480874)
19. Humpel C, Marksteiner J. Cerebrovascular damage as a cause for Alzheimer's disease. Curr Neurovasc Res 2005;2:341-347.
20. Verdile G, Fuller S, Atwood CS, Laws SM, Gandy SE, Martins RN. The role of beta amyloid in Alzheimer's disease: Still a cause of everything or the only one who got caught? Pharmacol Res 2004;50:397-409.
21. Anitschkow NN. Uber die veranderungen der kaninchenaorta bei experimenteller cholesterinsteatose. Beitr Pathol Anat 1913;56:379-404.
22. Finking G, Hanke J. Nikolaj Nicolajewisch Anitschkow (1885-1964) established the cholesterol-fed rabbit as a model for atherosclerosis research. Atherosclerosis 1997;135:1-7.
23. Jessup W, Kritharides L, Stocker R. Lipid peroxidation in atherogenesis: An overview. Biochem Soc Trans 2004;32:134-138.
24. Sparks DL, Scheff SW, Hunsaker JC III, Liu H, Landers T, Gross DR. Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol 1994;126:88-94.
25. Sjogren M, Mielke M, Gustafson D, Zandi P, Skoog I. Cholesterol and Alzheimer's disease - is there a relation? Mech Ageing Dev 2006;127:138-147.
26. Woodruff-Pak DS, Agelan A, Del Valle L. A rabbit model of Alzheimer's disease: Valid at neuropathological, cognitive, and therapeutic levels. J Alzheimers Dis 2007;11:371-383. (Pubitemid 47094031)
27. Sparks DL, Schreurs BG. Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc Natl Acad Sci U S A 2003;100:11065-11069.
28. Jack CR Jr, Shiung MM, Weigand SD, et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 2005;65:1227-1231.
29. Jack CR Jr, Petersen RC, O'Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-188.
30. Schreurs BG, Smith-Bell CA, Darwish DS, Stankovic G, Sparks DL. Classical conditioning of the rabbit's nictitating membrane response is a function of the duration of dietary cholesterol. Nutr Neurosci 2007;10:159-168. (Pubitemid 47490015)
31. Kapoor K, Kak VK, Singh B. Morphology and comparative anatomy of circulus arteriosus cerebri in mammals. Anat Histol Embryol 2003;32:347-355.
32. Majewska-Michalska E. The vertebrobasilar arterial system in guinea pig as compared with dog and human. Folia Morphol (Warsz) 1998;57:121-131. (Pubitemid 127444917)
33. Hoogeveen RM, Bakker CJ, Viergever MA. Limits to the accuracy of vessel diameter measurement in MR angiography. J Magn Reson Imaging 1998;8:1228-1235.
34. Jiang ZJ, Richardson JS, Yu PH. The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease. Neuropathol Appl Neurobiol 2008;34:194-204.
35. Vinters HV, Pardridge WM, Yang J. Immunohistochemical study of cerebral amyloid angiopathy: Use of an antiserum to a synthetic 28-amino-acid peptide fragment of the Alzheimer's disease amyloid precursor. Hum Pathol 1988;19:214-222. (Pubitemid 18091030)
36. Urban I, Richard P. A stereotaxic atlas of the New Zealand rabbit's brain. Springfield, IL: Thomas; 1973.
37. Welker W, Johnson JI, Noe A. (n.d.). Brain Atlas of the Domestic Rabbit. University of Wisconsin, Michigan State Comparative Mammalian Brain Collections, National Museum of Health and Medicine. Sponsored by National Science Foundation and National Institutes of Health. Available at: http://brainmuseum. org. Accessed 2007.
38. Jenkinson M, Bannister P, Brady M, Smith S. Improved optimisation for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002;17:825-841. (Pubitemid 35317016)
39. Cox RW. AFNI: Software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996;29:162-173. (Pubitemid 26266657)
40. Staekenborg SS, van Straaten EC, van der Flier WM, Lane R, Barkhof F, Scheltens P. Small vessel versus large vessel vascular dementia: Risk factors and MRI findings. J Neurol 2008;255:1644-1651.
41. Majewska-Michalska E. Vascularization of the brain in guinea pig. I. Gross anatomy of the arteries and veins. Folia Morphol (Warsz) 1994;53:249-268.
42. Sparks DL, Kuo YM, Roher A, Martin T, Lukas RJ. Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations. Ann N Y Acad Sci 2000;903:335-344.
43. Preston SD, Steart PV, Wilkinson A, Nicoll JA, Weller RO. Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: Defining the perivascular route for the elimination of amyloid beta from the human brain. Neuropathol Appl Neurobiol 2003;29:106-117. (Pubitemid 36408329)
44. Walker DA, Broderick DF, Kotsenas AL, Rubino FA. Routine use of gradient-echo MRI to screen for cerebral amyloid angiopathy in elderly patients. AJR Am J Roentgenol 2004;182:1547-1550.
45. Haacke EM, DelProposto ZS, Chaturvedi S, et al. Imaging cerebral amyloid angiopathy with susceptibility-weighted imaging. AJNR Am J Neuroradiol 2007;28:316-317. (Pubitemid 46281054)
46. Kurozumi T, Tanaka K, Yae Y. Hypertension-induced cerebral atherosclerosis in the cholesterol-fed rabbit. Atherosclerosis 1978;30:137-145. (Pubitemid 8353283)
47. Kanamaru K, Waga S, Tochio H, Nagatani K. The effect of atherosclerosis on endothelium-dependent relaxation in the aorta and intracranial arteries of rabbits. J Neurosurg 1989;70:793-798. (Pubitemid 19124194)
48. Nakayama S, Sakashita M, Tonooka M, Gotoh H, Yasuhara H, Sakamoto K. Experimental hyperlipidemia and atherosclerosis induced by cholesterol diet in SPF Japanese white rabbits. Jpn J Pharmacol 1983;33:279-289. (Pubitemid 13079912)
49. Hori E, Hayashi N, Hamada H, et al. A development of atheromatous plaque is restricted by characteristic arterial wall structure at the carotid bifurcation. Surg Neurol 2008;69:586-590; discussion 590-581.
50. Ford JC, Shlansky-Goldberg RD, Golden M. MR microscopy of the arterial wall in an experimental model of atherosclerosis: Preliminary results. J Vasc Interv Radiol 1997;8(Pt 1):93-99. (Pubitemid 27522856)
51. Jiang J, Haacke EM, Dong M. Dependence of vessel area accuracy and precision as a function of MR imaging parameters and boundary detection algorithm. J Magn Reson Imaging 2007;25:1226-1234. (Pubitemid 46870282)
52. Ronald JA, Chen Y, Bernas L, et al. Clinical field-strength MRI of amyloid plaques induced by low-level cholesterol feeding in rabbits. Brain 2009;132(Pt 5):1346-1354.
53. Moroe H, Honda H. Comparison of endothelial function in the carotid artery between normal and short-term hypercholesterolemic rabbits. Comp Biochem Physiol C Toxicol Pharmacol 2006;144:197-203. (Pubitemid 44602582)
54. Thal DR, Griffin WS, de Vos RA, Ghebremedhin E. Cerebral amyloid angiopathy and its relationship to Alzheimer's disease. Acta Neuropathol 2008;115:599-609.
55. Stokes KY, Cooper D, Tailor A, Granger DN. Hypercholesterolemia promotes inflammation and microvascular dysfunction: Role of nitric oxide and superoxide. Free Radic Biol Med 2002;33:1026-1036.
56. Suo Z, Su G, Placzek A, et al. A beta vasoactivity in vivo. Ann N Y Acad Sci 2000;903:156-163.
57. Price JM, Chi X, Hellermann G, Sutton ET. Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production. Neurol Res 2001;23:506-512. (Pubitemid 32642784)
58. Paris D, Humphrey J, Quadros A, et al. Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: Role of inflammation. Neurol Res 2003;25:642-651. (Pubitemid 37087609)
59. Townsend KP, Obregon D, Quadros A, et al. Proinflammatory and vasoactive effects of Abeta in the cerebrovasculature. Ann N Y Acad Sci 2002;977:65-76. (Pubitemid 35418137)
60. Roher AE, Kuo YM, Potter PE, et al. Cortical cholinergic denervation elicits vascular A beta deposition. Ann N Y Acad Sci 2000;903:366-373.
61. Vinters HV, Secor DL, Read SL, et al. Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: An immunohistochemical and ultrastructural study. Ultrastruct Pathol 1994;18:333-348.
62. Miyakawa T, Kuramoto R. Ultrastructural study of senile plaques and microvessels in the brain with Alzheimer's disease and Down's syndrome. Ann Med 1989;21:99-102. (Pubitemid 19139222)
63. Snowdon DA, Greiner LH, Markesbery WR. Linguistic ability in early life and the neuropathology of Alzheimer's disease and cerebrovascular disease. Findings from the Nun Study. Ann N Y Acad Sci 2000;903:34-38.